Member Info for Saxondale

Another Investor event booked in Jan 2022 - Stockholm Sweden
Redeye-Fight Cancer - Outlook 2022 - more details to follow .

Still to come Q4 -
Final dosing levels to be decided etc for pivotal trials
Soluble Clever 1 update ( Markku said expect updates into the Autumn )
First patient on Matins Lung trial
First patient on Neoadjuvant trial ( PD1 combi ?)
First patient on Heamatological study

Thanks Docu - two good bits from Sirpa & Maija

Our understanding is that the response of a drug does not depend so much on the type of cancer but on what immunological phenotype the patient represents. We will now explore what common factors the patients with the best response have.

People are different, individuals. Therefore, we need to invent new drug development targets. At the same time, diagnostic methods are needed to identify who is benefiting from a particular drug. It is a targeted treatment for diseases, Jalkanen explains.

This is the crucial element of an immunology drug - identifying who the targets should be .

Here we go with your 3-6 posts '1 month old dodge account' you won't last long here, believe me.... Spreading FUD - fear uncertainty and doubt - over the bulk underground, because that's essentially the only unknown left that such disingenuous posts can target.

Last year we had months and months of tecnhical FUD with the GreenTool and others - who said Havieron would never be economic... but here we are 12 months later with a gigantic starter deposit, a $50m decline going in, and $50m GGP cash funding to DFS, and a published phase 1 mine PFS to take to the bank ... so NCM can get ore to Telfer ASAP.

You may be able to confuse and scare the un-researched with your manipulation, but you cannot touch Bamps or me.

For the rest of you MrBig is a skilled and devious operator who last night was attempting to exploit an ostensibly clever argument. The posts were subsequently removed this am. For the correct reasons.

What he/she was trying to do last night was apply NCM's conservative, underground stoping phase 1 mine operational costs @ $84/tonne - actually $81/tonne according to GGP using the correct exchange rate to Bulk Underground production.

The first Stoping operation has naturally has lower volumes, due to the inherent volume limitations of the Stoping technique and higher costs - ore transport to surface limitation, requirement for drill and blast / explosives, and extra material handling, and subsequence labour in back pasting costs )

But you cannot apply this to the anticipated Bulk under ground block caving grades of the larger scale deposit where the cost per tonne would be circa $25-27/tonne

This is a totally and fundamentally inappropriate comparison made by BiggL - It's like comparing two completely different company cost structures, AND specifically designed to imply that anything under 1.5g is likely to be 'uneconomic'...

And It's total BS becuase we ALL know that Cadia is economic down to 0.4g/t Au... specifically due the bulk efficiencies of the operational costs.

And very much like comparing and interweaving the cost structure of building Ferraris directly to Ford Fiestas -

IE both make massive profits, BUT in TOTALLY different ways . Obviously You cannot make a profit building Ford fiestas in the way you build a Ferrari though. That would be loss making.

That's the best analogy I can come up with. And that is the tactic of this poster. Always Happy to smash them into touch.

Expect Multiple shorter accounts with a very obvious agenda.s

Regarding bulk underground : The only question is will this be a block cave or a more selective sub level cave...? Anyone with mining nouse can see that.. The grade in those breccia are nothing short of sensational. And a mine in their own right.

A fresh patent application published on 28th Oct 2021 ( last Thurs ) .
https://patents.justia.com/patent/20210332128

This one looks identical to two others published - but must have some differences as it is filed under a new patent .
So possibly as they discover more - so those findings need to be incorporated or updated into the patent regarding the agent responsible for binding to the Clever1 .

Topped up with 594 shares today - in one go lol !!
Still no idea about our mystery trader . 3.30 is a sell price , so its either some sticky button on someones computer , or somebody is flooding our site with large quantities of sell transactions ( albeit 1s ) to give the impression that there were 50 odd sells today . Very odd . My buy came up as a sell , as did the other few buys today .

Nas is up about 5% , first move off virtual flatlining for a long while .

Let's see if it comes to anything what with all these mysterious buys .

Captain Smirk may find some Shatner in his pants later

I'm tempted to buy a few , just in case this is the most blatant MM signalling effort in modern times .

On a side note , there's an Investor event just flagged up on Farons Calendar - Looks like a Finnish Investor channel Monday 15th Nov - pre recorded interview with Markku .

After hours Friday would be the best time for it - once again I could be a weekend millionaire , but this time come Monday I still would be haha

If Itsall sees them he's gonna have a heart attack lol . For the believers...

Also funny that despite appearing on LSE , neither the GGP or EUA RNS have appeared on my Vox Markets site .
It's almost as if someone wants to get a head start . 30 mins and no sign of them .

For due diligence to be completed , does that mean the JORC will also have to have been completed ?

There are definitely some invisible financial strings connected the EUA and GGP shares on AIM . These two big boys sometimes act like Gold and Silver , despite in theory being unconnected .
Happy either way today as I've got piles of both .

Game on ! explains all the horse dung on here yesterday lol

Wow indeed !!
Missed the podcast and only got to check the report after midnight - had to do a double take at that 10g/t result .
Staggering , stupendous , Shaun's gonna have to start inventing new words to describe Hav .
Maybe start sticking a odd ' farking' inside the words - like abos'farkin'lutely massive .

Thanks in advance for the podcast I'll be watching tonight with large beer .

Yes indeed thanks Juhis , they are back .
@FaronPharm is the page .
47 followers so far .

Also spotted Kaiku Health on twitter @KaikuHealth , and reminded me how enthusiastic Markku was about working with them on Matins patients , and how they hoped to work together again .

They recently received certification that enabled them to be used in support in US hospitals and meet requirements for certain regulatory bodies .
https://kaikuhealth.com/press/kaiku-health-achieves-2015-edition-onc-health-it-certification-in-the-us/

Who knows , but i wouldn't discount some further collaboration with Faron in the future .

Nope , it's very quiet out there .
Nothing in the calendar , no jobs advertised , twitter account removed after single post.
Apart from the dosing update to the trial site , its been radio silence .
Hollmen Lab have taken on some new staff and got some new fancy equipment - thats it .

After Esmo , and the flurry of press , then the placing - we are now left wondering what happened ?

All we have is the confidence that Markku was oozing , saying be patient - it's coming .
Timo tipping in the £5 million , along with the EIC .
No more hand holding for investors now - we have to just trust they are doing it right , for our eventual benefit .
Thankfully , Bex is under their control still , not open to disruption from any outside interventions . Their trial , their data .

On the other side , Traumakine could still be the joker in the pack for us . Interferon big in the headlines ( SNG ) - I'm surprised Faron still don't get a mention anywhere in the press . In my mind it's one of the most important trials out there , and to top it , they're comparing it to dexamethasone . Ok , its a risk doing that , but imagine if Traumakine comes up with data better than dex in that P2 initial trial . They'll have to rewrite the Covid handbook .

Patents sorted , manufacturing agreements and scale up arranged . US office . EIC and DofD funding . New management being hired . ESMO prestigious papers . Fully funded for next year .

It's just one of those periods where if you're feeling a bit uninspired , to just scan through all the RNS's we've had .

For any new investor , great entry point . You know the SP isn't being pumped up at the moment .

Very minor change to the Activ2 trial study status yesterday .
Only change was to alter the estimated completion date from December 2023 to December 31st 2023.

I wonder if such a seemingly pointless update has any relevance whatsoever ?

Looking at other trials I follow , some have specific dates , others just months .

There is a Faron Pharmaceuticals on Twitter ( @FaronPharmaceu2 ) - but its not the one I followed the other day , and the one that Maija and Dr Juho follow . That one has disappeared for some reason .

Maybe it was test ? Yes strange its gone .
Many of the company ones do tend to get a lot of abuse from disgruntled investors , and you obviously can't engage them .
I'm not bothered , when something big happens , we'll know about it .
Not sure how many of the Nordic investors would read it . I'm guessing English is pretty standard over there in the business world , but perhaps this was a plan to enlighten the folks in the USA a bit more ?

It would have been in auction GPS , too many trades so they have to suspend for a minute or two to catch up .

Goes to show , if you'd done your research and knew exactly what this last RNS signified , a top up was always going to be well rewarded .
Market moves in strange ways .
Holding all these now till the end .